Leap Therapeutics Announces Completion of Enrollment for First-Line Patient Cohort in Study of …,

The U.S. Food and Drug Administration has granted DKN-01 Orphan Drug Designation for the treatment of gastric and gastroesophageal junction …, The U.S. Food and Drug Administration has granted DKN-01 Orphan Drug Designation for the treatment of gastric and gastroesophageal junction …, Read More

Scroll to Top